|
1
|
Heideman DA, Lurkin I, Doeleman M, Smit
EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E and Zwarthoff
EC: KRAS and BRAF mutation analysis in routine molecular
diagnostics: Comparison of three testing methods on formalin-fixed,
paraffin-embedded tumor-derived DNA. J Mol Diagn. 14:247–255. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kanzler MH and Swetter SM: Malignant
melanoma. J Am Acad Dermatol. 48:780–783. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Streicher KL, Zhu W, Lehmann KP,
Georgantas RW, Morehouse CA, Brohawn P, Carrasco RA, Xiao Z, Tice
DA, Higgs BW, et al: A novel oncogenic role for the miRNA-506-514
cluster in initiating melanocyte transformation and promoting
melanoma growth. Oncogene. 31:1558–1570. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reintgen D, Cruse CW and Atkins M:
Cutaneous malignant melanoma. Clin Dermatol. 19:253–261. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Serrone L, Zeuli M, Sega FM and Cognetti
F: Dacarbazine-based chemotherapy for metastatic melanoma:
Thirty-year experience overview. J Exp Clin Cancer Res. 19:21–34.
2000.PubMed/NCBI
|
|
6
|
Alwan LM, Grossmann K, Sageser D, Van Atta
J, Agarwal N and Gilreath JA: Comparison of acute toxicity and
mortality after two different dosing regimens of high-dose
interleukin-2 for patients with metastatic melanoma. Target Oncol.
9:63–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Atkins MB, Lotze MT, Dutcher JP, Fisher
RI, Weiss G, Margolin K, Abrams J, Sznol M, Parkinson D, Hawkins M,
et al: High-dose recombinant interleukin 2 therapy for patients
with metastatic melanoma: Analysis of 270 patients treated between
1985 and 1993. J Clin Oncol. 17:2105–2116. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li N, Alam J, Venkatesan MI,
Eiguren-Fernandez A, Schmitz D, Di Stefano E, Slaughter N, Killeen
E, Wang X, Huang A, et al: Nrf2 is a key transcription factor that
regulates antioxidant defense in macrophages and epithelial cells:
Protecting against the proinflammatory and oxidizing effects of
diesel exhaust chemicals. J Immunol. 173:3467–3481. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bütof R, Dubrovska A and Baumann M:
Clinical perspectives of cancer stem cell research in radiation
oncology. Radiother Oncol. 108:388–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Baird L, Llères D, Swift S and
Dinkova-Kostova AT: Regulatory flexibility in the Nrf2-mediated
stress response is conferred by conformational cycling of the
Keap1-Nrf2 protein complex. Proc Natl Acad Sci USA.
110:15259–15264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Canning P, Sorrell FJ and Bullock AN:
Structural basis of KEAP1 interactions with Nrf2. Free Radic Biol
Med. 91:101–107. 2015. View Article : Google Scholar
|
|
12
|
Lee S, Lim MJ, Kim MH, Yu CH, Yun YS, Ahn
J and Song JY: An effective strategy for increasing the
radiosensitivity of human lung cancer cells by blocking
Nrf2-dependent antioxidant responses. Free Radic Biol Med.
53:807–816. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mcdonald JT, Kim K, Norris AJ, Vlashi E,
Phillips TM, Lagadec C, Della Donna L, Ratikan J, Szelag H, Hlatky
L and McBride WH: Ionizing radiation activates the Nrf2 antioxidant
response. Cancer Res. 70:8886–8895. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Singh A, Bodas M, Wakabayashi N, Bunz F
and Biswal S: Gain of Nrf2 function in non-small-cell lung cancer
cells confers radioresistance. Antioxid Redox Signal. 13:1627–1637.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shibata T, Ohta T, Tong KI, Kokubu A,
Odogawa R, Tsuta K, Asamura H, Yamamoto M and Hirohashi S: Cancer
related mutations in NRF2 impair its recognition by Keap1-Cu13 E3
ligase and promote malignancy. Proc Natl Acad Sci USA.
105:13568–13573. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao Q, Mao A, Yan J, Sun C, Di C, Zhou X,
Li H, Guo R and Zhang H: Downregulation of Nrf2 promotes
radiation-induced apoptosis through Nrf2 mediated Notch signaling
in non-small cell lung cancer cells. Int J Oncol. 48:765–773. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Konrad FM, Zwergel C, Ngamsri KC and
Reutershan J: Anti-inflammatory effects of heme oxygenase-1 depend
on adenosine A2A- and A2B-receptor signaling in acute pulmonary
inflammation. Front Immunol. 8:18742017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gęgotek A and Skrzydlewska E: The role of
transcription factor Nrf2 in skin cells metabolism. Arch Dermatol
Res. 307:385–396. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jeayeng S, Wongkajornsilp A, Slominski AT,
Jirawatnotai S, Sampattavanich S and Panich U: Nrf2 in
keratinocytes modulates UVB-induced DNA damage and apoptosis in
melanocytes through MAPK signaling. Free Radic Biol Med.
108:918–928. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rana T, Schultz MA, Freeman ML and Biswas
S: Loss of Nrf2 accelerates ionizing radiation-induced bone loss by
upregulating RANKL. Free Radic Biol Med. 53:2298–2307. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bravo-Cordero JJ, Hodgson L and Condeelis
J: Directed cell invasion and migration during metastasis. Curr
Opin Cell Biol. 24:277–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Khan N and Mukhtar H: Cancer and
metastasis: Prevention and treatment by green tea. Cancer
Metastasis Rev. 29:435–445. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu ZY, Lien JC, Huang YP, Liao CL, Lin JJ,
Fan MJ, Ko YC, Hsiao YP, Lu HF and Chung JG: Casticin inhibits
A375.S2 human melanoma cell migration/invasion through
downregulating NF-κB and matrix metalloproteinase-2 and −1.
Molecules. 21:3842016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo Y, Hu B, Huang H, Tsung A, Gaikwad NW,
Xu M, Jiang M, Ren S, Fan J, Billiar TR, et al: Estrogen
sulfotransferase is an oxidative stress responsive gene that
gender-specifically affects liver ischemia/reperfusion injury. J
Biol Chem. 290:14754–14764. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kobayashi EH, Suzuki T, Funayama R,
Nagashima T, Hayashi M, Sekine H, Tanaka N, Moriguchi T, Motohashi
H, Nakayama K and Yamamoto M: Nrf2 suppresses macrophage
inflammatory response by blocking proinflammatory cytokine
transcription. Nat Commun. 7:116242016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Geismann C, Arlt A, Sebens S and Schäfer
H: Cytoprotection ‘gone astray’: Nrf2 and its role in cancer. Onco
Targets Ther. 7:1497–1518. 2014.PubMed/NCBI
|
|
28
|
Hayes JD and McMahon M: NRF2 and KEAP1
mutations: Permanent activation of an adaptive response in cancer.
Trends Biochem Sci. 34:176–188. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ferrándiz ML, Nacher-Juan J and Alcaraz
MJ: Nrf2 as a therapeutic target for rheumatic diseases. Biochem
Pharmacol. 13:338–346. 2018. View Article : Google Scholar
|
|
30
|
Tsukimoto M, Tamaishi N, Homma T and
Kojima S: Low-dose gamma-ray irradiation induces translocation of
Nrf2 into nuclear in mouse macrophage RAW264.7 cells. J Radiat Res.
51:349–353. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meng D, Wang X, Chang Q, Hitron A, Zhang
Z, Xu M, Chen G, Luo J, Jiang B, Fang J and Shi X: Arsenic promotes
angiogenesis in vitro via a heme oxygenase-1-dependent mechanism.
Toxicol Appl Pharmacol. 244:291–299. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pan H, Wang H, Zhu L, Mao L, Qiao L and Su
X: The role of Nrf2 in migration and invasion of human glioma cell
U251. World Neurosurg. 80:363–370. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Menegon S, Columbano A and Giordano S: The
dual roles of NRF2 in cancer. Trends Mol Med. 22:578–593. 2016.
View Article : Google Scholar : PubMed/NCBI
|
